Bailey, MS; Green, AD; Ellis, CJ; O'Dempsey, TJ; Beeching, NJ; Lockwood, DN; Chiodini, PL; Bryceson, AD; (2005) Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel. Journal of the Royal Army Medical Corps, 151 (2). pp. 73-80. ISSN 0035-8665 https://researchonline.lshtm.ac.uk/id/eprint/8777 Full text not available from this repository.

Bhattarai, NR; Das, ML; Rijal, S; van der Auwera, G; Picado, A; Khanal, B; Roy, L; Speybroeck, N; Berkvens, D; Davies, CR; +3 more... Coosemans, M; Boelaert, M; Dujardin, JC; (2009) Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 103 (11). pp. 1087-1092. ISSN 0035-9203 DOI: https://doi.org/10.1016/j.trstmh.2009.03.008 Full text not available from this repository.

Chauviere, G; Bouteille, B; Enanga, B; de Albuquerque, C; Croft, SL; Dumas, M; Perie, J; (2003) Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead. Journal of medicinal chemistry, 46 (3). pp. 427-440. ISSN 0022-2623 DOI: https://doi.org/10.1021/jm021030a Full text not available from this repository.

Chibale, K; Haupt, H; Kendrick, H; Yardley, V; Saravanamuthu, A; Fairlamb, AH; Croft, SL; (2001) Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine. Bioorganic & medicinal chemistry letters, 11 (19). pp. 2655-2657. ISSN 0960-894X DOI: https://doi.org/10.1016/S0960-894X(01)00528-5 Full text not available from this repository.

Croft, SL; (2001) Monitoring drug resistance in leishmaniasis. Tropical medicine & international health, 6 (11). pp. 899-905. ISSN 1360-2276 https://researchonline.lshtm.ac.uk/id/eprint/16571 Full text not available from this repository.

Croft, SL; Seifert, K; Duchene, M; (2003) Antiprotozoal activities of phospholipid analogues. Molecular and biochemical parasitology, 126 (2). pp. 165-72. ISSN 0166-6851 DOI: https://doi.org/10.1016/S0166-6851(02)00283-9 Full text not available from this repository.

Croft, SL; Yardley, V; (2002) Chemotherapy of leishmaniasis. Current pharmaceutical design, 8 (4). pp. 319-42. ISSN 1381-6128 DOI: https://doi.org/10.2174/1381612023396258 Full text not available from this repository.

Croft, SL; Yardley, V; Kendrick, H; (2002) Drug sensitivity of Leishmania species: some unresolved problems. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96 Sup. S127-9. ISSN 0035-9203 https://researchonline.lshtm.ac.uk/id/eprint/16578 Full text not available from this repository.

Escobar, P; Matu, S; Marques, C; Croft, SL; (2002) Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta tropica, 81 (2). pp. 151-7. ISSN 0001-706X DOI: https://doi.org/10.1016/S0001-706X(01)00197-8 Full text not available from this repository.

García, AL; Parrado, R; Rojas, E; Delgado, R; Dujardin, JC; Reithinger, R; (2009) Leishmaniases in Bolivia: Comprehensive Review and Current Status. The American journal of tropical medicine and hygiene, 80 (5). pp. 704-11. ISSN 0002-9637 https://researchonline.lshtm.ac.uk/id/eprint/5329

Kayser, O; Kiderlen, AF; Croft, SL; (2003) Antileishmanial activity of two gamma-pyrones from Podolepsis hieracioides (Asteraceae). Acta tropica, 86 (1). pp. 105-107. ISSN 0001-706X DOI: https://doi.org/10.1016/S0001-706X(02)00258-9 Full text not available from this repository.

Kayser, O; Olbrich, C; Yardley, V; Kiderlen, AF; Croft, SL; (2003) Formulation of amphotericin B as nanosuspension for oral administration. International journal of pharmaceutics, 254 (1). pp. 73-75. ISSN 0378-5173 DOI: https://doi.org/10.1016/s0378-5173(02)00686-5 Full text not available from this repository.

Kropf, P; Bickle, Q; Herath, S; Klemenz, R; Muller, I; (2002) Organ-specific distribution of CD4(+) T1 /ST2(+) Th2 cells in Leishmania major infection. European journal of immunology, 32 (9). pp. 2450-2459. ISSN 0014-2980 DOI: https://doi.org/10.1002/1521-4141(200209)32:9<2450::AID-IMMU2450>3.0.CO;2-O Full text not available from this repository.

Lorente, SO; Jimenez, CJ; Gros, L; Yardley, V; de Luca-Fradley, K; Croft, SL; Urbina, JA; Ruiz-Perez, LM; Pacanowska, DG; Gilbert, IH; (2005) Preparation of transition-state analogues of sterol 24-methyl transferase as potential anti-parasities. Bioorganic & medicinal chemistry, 13 (18). pp. 5435-5453. ISSN 0968-0896 DOI: https://doi.org/10.1016/j.bmc.2005.06.012 Full text not available from this repository.

Magaraci, F; Jimenez, CJ; Rodrigues, C; Rodrigues, JCF; Braga, MV; Yardley, V; de Luca-Fradley, K; Croft, SL; de Souza, W; Ruiz-Perez, LM; +3 more... Urbina, J; Pacanowska, DG; Gilbert, IH; (2003) Azasterols as inhibitors of sterol 24-methyltransferase in leishmania species and Trypanosoma cruzi. Journal of medicinal chemistry, 46 (22). pp. 4714-4727. ISSN 0022-2623 DOI: https://doi.org/10.1021/jm021114j Full text not available from this repository.

Malik, AN; John, L; Bryceson, AD; Lockwood, DN; (2006) Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004. Emerging infectious diseases, 12 (8). pp. 1257-9. ISSN 1080-6040 https://researchonline.lshtm.ac.uk/id/eprint/7150

Mantyla, A; Garnier, T; Rautio, R; Nevalainen, T; Vepsalainen, J; Koskinen, A; Croft, SL; Jarvinen, T; (2004) Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone. Journal of medicinal chemistry, 47 (1). pp. 188-195. ISSN 0022-2623 DOI: https://doi.org/10.1021/jm030868a Full text not available from this repository.

Perez-Victoria, FJ; Sanchez-Canete, MP; Seifert, K; Croft, SL; Sundar, S; Castanys, S; Gamarro, F; (2006) Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug resistance updates, 9 (1-2). pp. 26-39. ISSN 1368-7646 DOI: https://doi.org/10.1016/j.drup.2006.04.001 Full text not available from this repository.

Quinnell, RJ; Courtenay, O; Shaw, MA; Day, MJ; Garcez, LM; Dye, C; Kaye, PM; (2001) Tissue cytokine responses in canine visceral leishmaniasis. The Journal of infectious diseases, 183 (9). pp. 1421-4. ISSN 0022-1899 https://researchonline.lshtm.ac.uk/id/eprint/16443 Full text not available from this repository.

Reithinger, R; Espinoza, JC; Davies, CR; (2003) The transmission dynamics of canine American cutaneous leishmaniasis in Huanuco, Peru. The American journal of tropical medicine and hygiene, 69 (5). pp. 473-80. ISSN 0002-9637 https://researchonline.lshtm.ac.uk/id/eprint/15133

Schonian, G; Kuhls, K; Mauricio, IL; (2011) Molecular approaches for a better understanding of the epidemiology and population genetics of Leishmania. Parasitology, 138 (4). pp. 405-425. ISSN 0031-1820 DOI: https://doi.org/10.1017/S0031182010001538

Yadon, ZE; Quigley, MA; Davies, CR; Rodrigues, LC; Segura, EL; (2001) Assessment of leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993. The American journal of tropical medicine and hygiene, 65 (1). pp. 27-30. ISSN 0002-9637 https://researchonline.lshtm.ac.uk/id/eprint/16522

Zemanova, E; Jirku, M; Mauricio, IL; Horak, A; Miles, MA; Lukes, J; (2007) The Leishmania donovani complex: Genotypes of five metabolic enzymes (ICD, ME, MPI, G6PDH, and FH), new targets for multilocus sequence typing. International journal for parasitology, 37 (2). pp. 149-160. ISSN 0020-7519 DOI: https://doi.org/10.1016/j.ijpara.2006.08.008 Full text not available from this repository.

de Ybanez, RR; del Rio, L; Martinez-Carrasco, C; Segovia, M; Cox, J; Davies, C; Berriatua, E; (2009) Questionnaire survey on Canine Leishmaniosis in southeastern Spain. Veterinary parasitology, 164 (2-4). pp. 124-133. ISSN 0304-4017 DOI: https://doi.org/10.1016/j.vetpar.2009.06.013 Full text not available from this repository.